Mastek Limited has received a one-year contract from NHS England to deliver cybersecurity training for executive boards and Senior Information Risk Owners (SIROs), as per the filing. The contract includes an option to extend for another year. The training will be conducted in partnership with Templar Executives.
The training programme has two components:
Both programmes are to address the growing need for cyber awareness at senior leadership levels across healthcare institutions.
Templar Executives will co-deliver the sessions with Mastek. The training is assured by the National Cyber Security Centre (NCSC), which provides guidelines for cybersecurity readiness in public sector organisations.
The sessions will be delivered over the duration of the contract period. They plan to build organisational capacity to handle cyber risks and align with legislative and compliance frameworks applicable to NHS entities.
Read More: Biocon Launches ₹4,500 Crore QIP to Strengthen Balance Sheet and Reduce Debt!
Mastek is a provider of digital and cloud transformation services. The company operates in over 40 countries with a workforce of more than 5,000. It works with clients across healthcare, public services, education, and finance.
Templar Executives is a cybersecurity consultancy that offers advisory and training services across various sectors, including healthcare, defence, and infrastructure. They work with leadership teams and frontline staff to improve cyber risk management.
As of 9:30 AM on June 17, 2025, Mastek share price was trading at ₹2,507.50, a 0.33% increase; the stock has declined 22.30% over the past 6 months and 6.43% over the past year.
The contract is the start of a formal training aimed at improving cybersecurity governance across NHS England. The focus is on building awareness and preparedness among key decision-makers through structured training programmes.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 17, 2025, 10:19 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates